Joaquim Soler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joaquim Soler has a total of 466 co-authors. Here are the top co-authors by number of shared publications:
- Juan Carlos Pascual
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Institut de Recerca Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain
56 shared publications - Víctor Pérez
Hospital del Mar
29 shared publications - Albert Feliu-Soler
Department of Clinical and Health Psychology, Faculty of Psychology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain
25 shared publications - Ausiàs Cebolla
Department of Personality, Evaluation and Psychological Treatment University of Valencia Valencia Spain
20 shared publications Matilde Elices
18 shared publicationsJuan C. Pascual
Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III
17 shared publications
Latest Publications
- 1 November 2026
- Published by American Psychological Association (APA) in Personality Disorders: Theory, Research, and Treatment
- Vol. 17 (6) , 460-473
Stand-alone dialectical behavior therapy skills training for borderline personality disorder: A systematic review and meta-analysis.
Stand-alone dialectical behavior therapy skills training groups (DBT-ST) are widely used for borderline personality disorder (BPD), yet skills-specific benchmarks for symptom change and tolerability are unclear. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched PubMed, APA PsycARTICLES, APA PsycINFO, Psicodoc, and Psyke (English/Spanish) for adult stand-alone DBT-ST covering the four standard modules. Eligible designs were randomized clinical trials, controlled trials, and pre-post studies with standardized BPD diagnoses. Continuous outcomes were synthesized as standardized mean differences (Hedges-corrected d); within-arm pre-post effects used standardized mean change (assumed r = .50 when missing). Dropout was pooled on the logit scale and back transformed to retention. Random-effects model with Hartung-Knapp adjustments quantified heterogeneity and ran sensitivity/bias diagnostics. Seven studies met criteria; five entered meta-analysis. BPD clinical severity showed large within-arm improvement (d = -1.32, 95% confidence interval [CI; -1.99, -0.64]) with substantial heterogeneity. Depression decreased largely (k = 4; d = -1.04, 95% CI [-1.33, -0.75]); global psychopathology decreased moderately (k = 2; d = -0.73, 95% CI [-1.39, -0.08]). Pooled dropout was 29% (95% CI [23%, 36%]), implying 71% retention. Stand-alone DBT-ST is associated with large symptom reductions and acceptable retention, providing skills-specific benchmarks to inform implementation, whereas heterogeneity indicates the need for more robust comparative trials. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
- 1 November 2026
- Published by American Psychological Association (APA) in Personality Disorders: Theory, Research, and Treatment
- Vol. 17 (6) , 460-473
Stand-alone dialectical behavior therapy skills training for borderline personality disorder: A systematic review and meta-analysis.
Stand-alone dialectical behavior therapy skills training groups (DBT-ST) are widely used for borderline personality disorder (BPD), yet skills-specific benchmarks for symptom change and tolerability are unclear. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched PubMed, APA PsycARTICLES, APA PsycINFO, Psicodoc, and Psyke (English/Spanish) for adult stand-alone DBT-ST covering the four standard modules. Eligible designs were randomized clinical trials, controlled trials, and pre-post studies with standardized BPD diagnoses. Continuous outcomes were synthesized as standardized mean differences (Hedges-corrected d); within-arm pre-post effects used standardized mean change (assumed r = .50 when missing). Dropout was pooled on the logit scale and back transformed to retention. Random-effects model with Hartung-Knapp adjustments quantified heterogeneity and ran sensitivity/bias diagnostics. Seven studies met criteria; five entered meta-analysis. BPD clinical severity showed large within-arm improvement (d = -1.32, 95% confidence interval [CI; -1.99, -0.64]) with substantial heterogeneity. Depression decreased largely (k = 4; d = -1.04, 95% CI [-1.33, -0.75]); global psychopathology decreased moderately (k = 2; d = -0.73, 95% CI [-1.39, -0.08]). Pooled dropout was 29% (95% CI [23%, 36%]), implying 71% retention. Stand-alone DBT-ST is associated with large symptom reductions and acceptable retention, providing skills-specific benchmarks to inform implementation, whereas heterogeneity indicates the need for more robust comparative trials. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
- 14 July 2026
- Published by Springer Nature in Mindfulness
- Vol. 17 (9) , 2571-2583
Effects of a Dialectical Behavior Therapy Zen Retreat on Affect and Well-Being in Healthcare Workers
- 14 July 2026
- Published by Springer Nature in Mindfulness
- Vol. 17 (9) , 2571-2583
Effects of a Dialectical Behavior Therapy Zen Retreat on Affect and Well-Being in Healthcare Workers
- 17 June 2026
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117294
Promoting self-compassion meditation with intranasal oxytocin in Borderline Personality Disorder: a pilot study
- 17 June 2026
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117294
Promoting self-compassion meditation with intranasal oxytocin in Borderline Personality Disorder: a pilot study
- 12 February 2026
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 40 (2)
Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder
- 12 February 2026
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 40 (2)
Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder
- Open Access
- 27 January 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e86413
A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial
Background: Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies. Objective: This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol. Methods: This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups. Results: Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing. Conclusions: This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. Trial Registration: International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 International Registered Report Identifier (IRRID): DERR1-10.2196/86413
- 27 January 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e86413
Open AccessA Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial
Background: Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies. Objective: This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol. Methods: This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups. Results: Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing. Conclusions: This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. Trial Registration: International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 International Registered Report Identifier (IRRID): DERR1-10.2196/86413
- Open Access
- 27 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial (Preprint)
BACKGROUND Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies. OBJECTIVE This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol. METHODS This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups. RESULTS Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing. CONCLUSIONS This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. CLINICALTRIAL International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/86413
- 27 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial (Preprint)
BACKGROUND Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies. OBJECTIVE This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol. METHODS This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups. RESULTS Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing. CONCLUSIONS This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. CLINICALTRIAL International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/86413
- 21 March 2025
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 39 (2)
Scale to measure dialectical thinking from dialectical behavior therapy perspective.
- 21 March 2025
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 39 (2)
Scale to measure dialectical thinking from dialectical behavior therapy perspective.
- Open Access
Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
Open AccessGenome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.